24.01.2017 19:10:00
|
Respiratory Disorders Pipeline Database 2017 - Chronic obstructive pulmonary disease, Sinusitis (Acute and Chronic), Asthma, Bronchitis (Acute and Chronic) - Research and Markets
DUBLIN, Jan 24, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Respiratory Disorders Pipeline Database - 2017" drug pipelines to their offering.
Respiratory Disorders Pipeline Highlights Database - 2017, provides most up-to-date information on key pipeline products in the global Respiratory Disorders Drug market. It covers emerging therapies for Respiratory Disorders in active clinical development stages including early and late stage clinical trials.
Key indications covered in this database include Chronic obstructive pulmonary disease, Sinusitis (Acute and Chronic), Asthma, Bronchitis (Acute and Chronic). The pipeline data is presented in an excel dashboard with filtering options.
The pipeline data presented in this database helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
By Indication:
The database presents pipeline by Respiratory Disorders indications. Key indications covered in this database include Chronic obstructive pulmonary disease, Sinusitis (Acute and Chronic), Asthma, Bronchitis (Acute and Chronic).
By Clinical Trial Stages:
The database provides Respiratory Disorders pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
By Drug Mechanism Classes:
The database provides Respiratory Disorders pipeline products by their dominant drug mechanism class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
By Company:
The database provides Respiratory Disorders pipeline products by the company.
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/6qhhww/respiratory
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/respiratory-disorders-pipeline-database-2017---chronic-obstructive-pulmonary-disease-sinusitis-acute-and-chronic-asthma-bronchitis-acute-and-chronic---research-and-markets-300395693.html
SOURCE Research and Markets

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!